Analysts forecast the global POC blood glucose monitoring devices market to grow at a USD 2,036.4 million during the period 2018-2022. The latest trend gaining momentum in the market is Paradigm shift towards non-invasive products.
Access Sample Report at www.reportsnreports.com/contacts/r…aspx?name=1346572.
The non-invasive POC blood glucose monitoring devices are hand-held devices that offer numerous benefits over finger prick glucose test such.
Non-invasive POC blood glucose monitoring helps to avoid finger prick, which is a convenient, easy to read large number display. Moreover, it can track patient compliance, and multiple test can help to provide adequate therapeutic decisions by healthcare providers.
Major key players in the global POC blood glucose monitoring devices market: Abbott, ARKRAY, Ascensia Diabetes Care, Danaher, F. Hoffmann -La Roche, and Johnson & Johnson
According to the POC blood glucose monitoring devices market report, one of the major drivers for this market is Public and private initiatives to reduce diabetic cases. There is an increasing case of lifestyle diseases such as diabetes, which affects individual's ability to turn food into energy.
Diabetes is of three types: type 1, type 2, and gestational diabetes (diabetes during pregnancy). According to CDC, as on 2017, approximately 30.3 million individuals residing in the US have diabetes, and more than 95% of these diabetic patients have type 2 diabetes.
Type 2 diabetes is caused owing to several factors such as heredity, obesity, unhealthy diet, and sedentary lifestyle.
Further, the POC blood glucose monitoring devices market report states that one of the major factors hindering the growth of this market is High cost associated with diabetes management. Majority of POC blood glucose monitoring devices manufactured by various global and local players are cost-efficient.
However, the cost associated with diabetes management in high, leading to out of -pocket expenditure for consumables used in POC blood glucose monitoring devices. Consumables such as blood glucose test strips, reagents, and cassettes are expensive and are required for daily usage.
An invasive device such as lancet is bought separately along with the POC blood monitoring devices, leading to additional cost incurred.
Access report at www.reportsnreports.com/purchase.aspx?name=1346572.
Few Points from List of Exhibits:
Exhibit 1: Parent Market
Exhibit 2: Global Ivd Market
Exhibit 3: Market Characteristics
Exhibit 4: Market Segments
Exhibit 5: Market Definition - Inclusions and Exclusions Checklist
Exhibit 6: Market Size 2017
Exhibit 7: Validation Techniques Employed For Market Sizing 2017
Exhibit 8: Global Market Size and Forecast 2017-2022 ($ Mn)
Exhibit 9: Global Year Over Year Growth 2018-2022 (%)
Exhibit 10: Five Forces Analysis 2017
Exhibit 11: Five Forces Analysis 2022
Exhibit 12: Bargaining Power of Buyers
Exhibit 13: Bargaining Power of Suppliers
Exhibit 14: Threat of New Entrants
Exhibit 15: Threat of Substitutes
Exhibit 16: Threat of Rivalry
Exhibit 17: Market Condition - Five Forces 2017
Exhibit 18: Global Poc Blood Glucose Monitoring Devices by Product Market Share 2017-2022 (%)
Exhibit 19: Comparison by Product
Exhibit 20: Consumables Market Size and Forecast 2017-2022 ($ Mn)